Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Insulin-like growth factor 2 mRNA binding protein 3 (
IGF2BP3
/IMP3/KOC), initially identified as an RNA-binding protein, is highly expressed in embryonic tissues and a variety of cancers. Previously, our group reported that
IGF2BP3
may serve as a potential diagnostic marker for lung cancer. However, little is known about the function of
IGF2BP3
in lung cancer development. Here we demonstrate that
IGF2BP3
expression was markedly increased in lung cancer tissues compared to normal tissues at both mRNA and protein levels. Overexpression of
IGF2BP3
in lung cancer cells promoted cell proliferation, tumor migration and invasion
in vitro
and
in vivo
, whereas knockdown of
IGF2BP3
exhibited opposite effects. Notably
IGF2BP3
was directly associated with a deubiquitinase
Ubiquitin
specific peptidase 10 (USP10) and attenuated its function in stabilizing p53 protein. Silencing
IGF2BP3
expression in lung cancer cells consistently increased the half-life and protein level of p53 and induced G0/G1 arrest. Thus, our data together demonstrate that
IGF2BP3
promotes lung tumorigenesis via attenuating p53 protein stability.
...
PMID:Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability. 2921 81